Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives

MF Dias, K Joo, JA Kemp, SL Fialho… - Progress in retinal and …, 2018 - Elsevier
Retinitis Pigmentosa (RP) is a hereditary retinopathy that affects about 2.5 million people
worldwide. It is characterized with progressive loss of rods and cones and causes severe …

Mechanisms of photoreceptor death in retinitis pigmentosa

F Newton, R Megaw - Genes, 2020 - mdpi.com
Retinitis pigmentosa (RP) is the most common cause of inherited blindness and is
characterised by the progressive loss of retinal photoreceptors. However, RP is a highly …

The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy

D Athanasiou, M Aguila, J Bellingham, W Li… - Progress in retinal and …, 2018 - Elsevier
Inherited mutations in the rod visual pigment, rhodopsin, cause the degenerative blinding
condition, retinitis pigmentosa (RP). Over 150 different mutations in rhodopsin have been …

Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases

N Cuenca, L Fernández-Sánchez, L Campello… - Progress in retinal and …, 2014 - Elsevier
Retinal neurodegenerative diseases like age-related macular degeneration, glaucoma,
diabetic retinopathy and retinitis pigmentosa each have a different etiology and …

Tauroursodeoxycholate—bile acid with chaperoning activity: molecular and cellular effects and therapeutic perspectives

M Kusaczuk - Cells, 2019 - mdpi.com
Tauroursodeoxycholic acid (TUDCA) is a naturally occurring hydrophilic bile acid that has
been used for centuries in Chinese medicine. Chemically, TUDCA is a taurine conjugate of …

[HTML][HTML] Neuroprotective strategies for retinal disease

MT Pardue, RS Allen - Progress in retinal and eye research, 2018 - Elsevier
Diseases that affect the eye, including photoreceptor degeneration, diabetic retinopathy, and
glaucoma, affect 11.8 million people in the US, resulting in vision loss and blindness. Loss of …

Primary cilia in the developing and mature brain

A Guemez-Gamboa, NG Coufal, JG Gleeson - Neuron, 2014 - cell.com
Primary cilia were the largely neglected nonmotile counterparts of their better-known cousin,
the motile cilia. For years these nonmotile cilia were considered evolutionary remnants of …

The unexpected uses of urso-and tauroursodeoxycholic acid in the treatment of non-liver diseases

S Vang, K Longley, CJ Steer… - Global advances in …, 2014 - journals.sagepub.com
Tauroursodeoxycholic acid (TUDCA) is the taurine conjugate of ursodeoxycholic acid
(UDCA), a US Food and Drug Administration—approved hydrophilic bile acid for the …

Targeting microglia to treat degenerative eye diseases

SK Wang, CL Cepko - Frontiers in immunology, 2022 - frontiersin.org
Microglia have been implicated in many degenerative eye disorders, including retinitis
pigmentosa, age-related macular degeneration, glaucoma, diabetic retinopathy, uveitis, and …

Inherited retinal dystrophies: role of oxidative stress and inflammation in their physiopathology and therapeutic implications

I Pinilla, V Maneu, L Campello, L Fernández-Sánchez… - Antioxidants, 2022 - mdpi.com
Inherited retinal dystrophies (IRDs) are a large group of genetically and clinically
heterogeneous diseases characterized by the progressive degeneration of the retina …